Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Leukemia ; 18(9): 1505-11, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15284856

ABSTRACT

Infantile malignant osteopetrosis (IMO) is a rare and lethal disease characterized by an absence of bone resorption due to inactive OCLs. Affected patients display an increased bone mass and hematological defects. The osteopetrotic oc/oc mouse displays a bone phenotype similar to the one observed in IMO patients, and the same gene, Tcirg1, is mutated in this model and in the majority of these patients. Therefore, we explored in oc/oc mice the consequences of the perturbed bone microenvironment on hematopoiesis. We show that the myelomonocytic differentiation is increased, leading to an elevated number of OCLs and dendritic cells. B lymphopoiesis is blocked at the pro-B stage in the bone marrow of oc/oc mouse, leading to a low mature B-cell number. T-cell activation is also affected, with a reduction of IFNgamma secretion by splenic CD4(+) T cells. These alterations are associated with a low IL-7 expression in bone marrow. All these data indicate that the lack of bone resorption in oc/oc mice has important consequences in both myelopoiesis and lymphopoiesis, leading to a form of immunodeficiency. The oc/oc mouse is therefore an appropriate model to understand the hematological defects described in IMO patients, and to derive new therapeutic strategies.


Subject(s)
Bone Resorption , Hematopoiesis/physiology , Lymphopoiesis/physiology , Osteopetrosis/pathology , Animals , B-Lymphocytes/cytology , Bone Marrow/metabolism , Bone Marrow/pathology , Cell Differentiation , Dendritic Cells/metabolism , Dendritic Cells/pathology , Disease Models, Animal , Hematopoiesis/genetics , Interferon-gamma/metabolism , Interleukin-7/metabolism , Lymphocyte Activation , Mice , Mice, Inbred C3H , Mice, Inbred C57BL , Mice, Knockout , Osteoclasts/metabolism , Osteopetrosis/metabolism , Spleen/immunology , T-Lymphocytes/cytology
2.
J Immunol ; 167(6): 3107-13, 2001 Sep 15.
Article in English | MEDLINE | ID: mdl-11544295

ABSTRACT

Induction and maintenance of peripheral tolerance is an important phenomenon for the control of homeostasis in the immune system. There is now compelling evidence for CD4(+) T cells that prevent immune pathology, both in autoimmunity and in transplantation. However, the mechanisms involved in the specific differentiation of these T cells are unknown. We had previously shown that repetitive stimulations of naive T cells in the presence of IL-10 induce the differentiation of T regulatory cells 1. We further dissected the mechanism of IL-10 function and demonstrated that IL-10 acts by the down-regulation of most costimulatory molecules without modifying the expression of CD58. Using artificial APCs expressing various costimulatory molecules, we demonstrated that, in contrast to other costimulation patterns, costimulation via CD2 alone, in the absence of costimulations through CD28- or LFA-1, induced T cell anergy in an IL-10-independent pathway along with the differentiation of Ag-specific regulatory T cells. T regulatory cell-1 differentiation via CD2 was very efficient as both high IL-10 secretion and regulatory function were observed after the first stimulation of naive T cells with CD32-CD58 L cells. The possibility to rapidly induce the differentiation of Ag-specific regulatory T cells will certainly accelerate their characterization and their potential use as regulators of T cell-mediated diseases.


Subject(s)
CD2 Antigens/physiology , Th1 Cells/cytology , Animals , Antigen Presentation , B-Lymphocytes/immunology , B7-1 Antigen/physiology , CD58 Antigens/physiology , Cell Differentiation/drug effects , Cell Line, Transformed , Clonal Anergy/drug effects , Culture Media, Conditioned/pharmacology , Humans , Interleukin-1/pharmacology , Interleukin-10/pharmacology , Interleukin-10/physiology , L Cells , Lymphokines/metabolism , Mast-Cell Sarcoma/pathology , Mice , Receptors, IgG/physiology , Recombinant Proteins/pharmacology , Th1 Cells/drug effects , Th1 Cells/metabolism , Transfection , Tumor Cells, Cultured
3.
Cell Mol Biol (Noisy-le-grand) ; 47(1): 167-78, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11292252

ABSTRACT

To establish new tools for studying human thymic stromal cells, we transfected adherent cells from a human postnatal thymus using a plasmid encoding SV40 large T antigen. Among the cell lines obtained, we characterized four epithelial cell lines (LT-TEC1 to LT-TEC4) and one thymic myoid cell line (MITC). Several morphological, functional and phenotypic differences were observed between these 2 cell types. Epithelial cells were heterogeneous and larger than myoid cells. Untreated LT-TEC lines expressed MHC class I, ICAM-1 and LFA-3 antigens and not MHC class II antigens, similarly to primary thymic epithelial cells (PTEC), while MITC line expressed only class I and LFA-3 antigens. After IFN-gamma treatment, MHC class II and ICAM-1 antigens were markedly upregulated in LT-TEC lines but not in MITC, indicating the absence or a dysfunction of regulatory factors in MITC line. Myoid cells expressed mRNA for all the subunits of the acetylcholine receptor (AChR) while epithelial cells expressed only the alpha, beta and epsilon subunits. Strikingly, LT-TEC produced much more C-C chemokines and IL-6 than MITC cells, while these latter produced higher levels of IL-8 and TNF-alpha. Altogether, these results reveal phenotypic and functional differences between these two stromal cell types, suggesting a potential involvement of myoid cells in the thymic function.


Subject(s)
Thymus Gland/cytology , Animals , Antigens, Polyomavirus Transforming/genetics , CD58 Antigens/biosynthesis , Cell Line, Transformed , Cells, Cultured , Cytokines/biosynthesis , Histocompatibility Antigens Class I/biosynthesis , Histocompatibility Antigens Class II/biosynthesis , Humans , Infant , Intercellular Adhesion Molecule-1/biosynthesis , Interferon-gamma/immunology , Interferon-gamma/pharmacology , Mice , Mice, Inbred BALB C , Phenotype , Receptors, Cholinergic/biosynthesis , Stromal Cells/classification , Stromal Cells/cytology , Stromal Cells/drug effects , Stromal Cells/physiology
4.
Eur Cytokine Netw ; 11(2): 153-60, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10903794

ABSTRACT

Interleukin-10 (IL-10) is a cytokine that is currently regarded as a potential therapy for inflammatory diseases involving T helper 1-type responses because of its ability to downregulate several major functions of Th1 cells and macrophages. There are also evidence that IL-10 could be useful in controlling Th2-mediated inflammatory processes. However IL-10 has also immunostimulatory properties especially on B-cells and activated CD8+ T cells. These pleiotropic effects may explain the discrepancy observed after IL-10 treatment in different in vivo experimental models. We have recently shown that IL-10 induces the differentiation of a subset of regulatory CD4+ T cells (Tr1). In different in vivo models, these cells were shown to inhibit Th1 and Th2-type inflammatory responses through the secretion of IL-10. These Tr1 cells may thus be used in specific cellular therapy in order to deliver IL-10 precisely at the site of inflammation.


Subject(s)
Interleukin-10/pharmacology , Adjuvants, Immunologic/pharmacology , Animals , Autoimmune Diseases/drug therapy , Autoimmune Diseases/immunology , Autoimmunity , Cell Differentiation/drug effects , Cytokines/pharmacology , Humans , Hypersensitivity/immunology , Immunosuppressive Agents/pharmacology , In Vitro Techniques , Interleukin-10/genetics , Interleukin-10/physiology , Mice , T-Lymphocytes/cytology , T-Lymphocytes/drug effects , T-Lymphocytes/immunology
5.
Am J Pathol ; 155(4): 1229-40, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10514405

ABSTRACT

The subset of myoid cells is a normal component of the thymic stroma. To characterize these cells, we immortalized stromal cells from human thymus by using a plasmid vector encoding the SV40 T oncogene. Among the eight cell lines obtained, one had myoid characteristics including desmin and troponin antigens. This new line was designated MITC (myoid immortalized thymic cells). These cells expressed both the fetal and adult forms of muscle acetylcholine receptor (AChR) at the mRNA level, as well as the myogenic transcription factor MyoD1. alpha-Subunit AChR protein expression was detected by flow cytometry and the AChR was functional in patch-clamp studies. In addition, AChR expression was down-modulated by myasthenia gravis sera or by monoclonal antibody anti-AChR on MITC line similarly to TE671 rhabdomyosarcoma cells, making the MITC line an interesting tool for AChR antigenic modulation experiments. Finally, the MITC line expressed LFA-3, produced several cytokines able to act on T cells, and protected total thymocytes from spontaneous apoptosis in vitro. These results are compatible with a role of thymic myoid cells in some steps of thymocyte development. Therefore MITC line appears to be a useful tool to investigate the physiological role of thymic myoid cells.


Subject(s)
Stromal Cells/cytology , Thymus Gland/cytology , Antigenic Modulation/drug effects , Antigens, Viral, Tumor/biosynthesis , Antigens, Viral, Tumor/genetics , Apoptosis , Autoantibodies/pharmacology , Blotting, Northern , Cell Line , Child , Cytokines/biosynthesis , Flow Cytometry , Humans , Immunophenotyping , In Vitro Techniques , Myasthenia Gravis/immunology , MyoD Protein/biosynthesis , Patch-Clamp Techniques , RNA, Messenger/metabolism , Receptors, Cholinergic/biosynthesis , Receptors, Cholinergic/immunology , Receptors, Cholinergic/physiology , Stromal Cells/drug effects , Stromal Cells/metabolism , Stromal Cells/physiology , Thymus Gland/drug effects , Thymus Gland/metabolism , Thymus Gland/physiology , Transfection
6.
J Immunol ; 162(4): 2103-12, 1999 Feb 15.
Article in English | MEDLINE | ID: mdl-9973484

ABSTRACT

The molecular and functional expression of serpentine membrane receptors for vasoactive intestinal peptide (VIP), calcitonin gene-related peptide (CGRP), and calcitonin (CT) were characterized in human thymus and thymomas from myasthenia gravis (MG) patients and thymic epithelial cells either in primary culture (PTEC) or transformed by the simian virus 40 large T (SV40LT) oncogene (LT-TEC). Using RT-PCR combined with Southern analysis, we identified the PCR products corresponding to the receptor (-R) transcripts for VIP, CGRP, and CT in thymus from control subjects and MG patients with either hyperplasia or thymoma. Similar expressions of the VIP- and CGRP-R transcripts were observed in PTEC, whereas the CT-R message was not detected. In LT-TEC, the signals for VIP-R, CGRP-R, and CT-R transcripts were seen with a lower intensity than those in control and MG thymus. In agreement with our molecular analysis, 1) VIP was the most potent peptide among VIP-related peptides (VIP > PACAP > PHM > PHV) to stimulate cAMP production through specific type 1 VIP receptors in both PTEC and LT-TEC; 2) cAMP generation was induced by CGRP in PTEC and by CT in LT-TEC; 3) in frozen thymic sections and by flow cytometry, type 1 VIP-R, CGRP-R, and CT-R were localized in epithelial cells; and 4) in parallel, the transcription of the acetylcholine receptor alpha subunit (the main autoantigen in MG) was induced by CGRP and CT in PTEC and LT-TEC, respectively. Our data suggest that the neuroendocrine peptides VIP, CGRP, and CT may exert functional roles during MG and malignant transformation of the human thymus.


Subject(s)
Myasthenia Gravis/metabolism , Receptors, Neuropeptide/biosynthesis , Receptors, Neuropeptide/physiology , Thymoma/metabolism , Thymus Gland/metabolism , Adolescent , Adult , Antigens, Viral, Tumor/physiology , Blotting, Southern , Calcitonin/pharmacology , Calcitonin Gene-Related Peptide/pharmacology , Cell Culture Techniques/methods , Cell Line, Transformed , Cell Transformation, Viral , Child , Child, Preschool , Epithelial Cells/cytology , Epithelial Cells/metabolism , Flow Cytometry , Gene Expression Regulation/drug effects , Gene Expression Regulation/immunology , Humans , Immunohistochemistry , Infant , Middle Aged , Myasthenia Gravis/immunology , Receptors, Calcitonin/biosynthesis , Receptors, Calcitonin/genetics , Receptors, Calcitonin/physiology , Receptors, Calcitonin Gene-Related Peptide/biosynthesis , Receptors, Calcitonin Gene-Related Peptide/genetics , Receptors, Calcitonin Gene-Related Peptide/physiology , Receptors, Cholinergic/genetics , Receptors, Neuropeptide/genetics , Receptors, Vasoactive Intestinal Peptide/biosynthesis , Receptors, Vasoactive Intestinal Peptide/genetics , Receptors, Vasoactive Intestinal Peptide/physiology , Reverse Transcriptase Polymerase Chain Reaction , Simian virus 40/physiology , Thymus Gland/cytology , Vasoactive Intestinal Peptide/pharmacology
8.
J Clin Invest ; 102(1): 249-63, 1998 Jul 01.
Article in English | MEDLINE | ID: mdl-9649579

ABSTRACT

Myasthenia gravis (MG) is a neuromuscular disorder mediated by antibodies directed against the acetylcholine receptor (nAChR) resulting in a functional nAChR loss. To analyze the molecular mechanisms involved at the muscular target site, we studied the expression of nAChR subunits in muscle biopsy specimens from MG patients. By using quantitative PCR with an internal standard for each subunit, we found that the levels of beta-, delta-, and epsilon-subunit mRNA coding for the adult nAChR were increased in severely affected MG patients, matching our previous data on the alpha-subunit. Messenger levels were highly variable in MG patients but not in controls, pointing to individual factors involved in the regulation of nAChR genes. The fetal subunit (gamma-chain) transcripts were almost undetectable in the extrajunctional region of MG muscle, suggesting that gene regulation in MG differs from that in the denervation model, in which nAChR gamma-subunit mRNA is reexpressed. Nicotinic AChR loss mediated by monoclonal anti-nAChR antibodies in both the TE671 muscle cell line and cultured normal human myotubes induces a similar increase in beta- alphand delta-subunit mRNA levels, suggesting the existence of a new muscular signaling pathway system coupled to nAChR internalization and independent of muscle electrical activity. These data demonstrate the existence of a compensatory mechanism regulating the expression of the genes coding for the adult nAChR in patients with MG.


Subject(s)
Gene Expression Regulation , Muscles/metabolism , Myasthenia Gravis/metabolism , Receptors, Nicotinic/genetics , Adolescent , Adult , Cell Line , Disease Models, Animal , Female , Humans , Male , Middle Aged , RNA, Messenger/analysis , Transcription, Genetic
9.
J Immunol ; 157(8): 3752-60, 1996 Oct 15.
Article in English | MEDLINE | ID: mdl-8871679

ABSTRACT

The intrathymic presence of the muscle acetylcholine receptor (AChR) is controversial, and the nature of the cell(s) expressing it is unclear. We thus analyzed the molecular expression of muscle AChR in human thymi. mRNA studies indicated that the two isoforms (P3A+ and P3A-) of the alpha-subunit were present in thymic extracts and in cultured thymic epithelial cells (TEC), while expression in thymocytes was low and not consistently detectable. The amount of mRNA coding for the alpha-subunit, evaluated by means of quantitative PCR, was about 20 times less in TEC than in muscle, and was similar in TEC from normal subjects and from patients with myasthenia gravis (MG). The beta- and epsilon-subunits present in adult AChR were also expressed in TEC (but not in thymocytes), while the embryonic subunit (gamma) was absent. In TEC cultures, the AChR alpha- and epsilon-subunit mRNA levels were down-regulated by forskolin, as also observed in the TE671 rhabdomyosarcoma cell line, suggesting similar regulation of AChR subunits in thymus and muscle. Protein expression was evidenced on TEC (but not on thymocytes), by Western blotting as well as by immunofluorescence, thus demonstrating AChR expression on human thymic epithelial cells. There was no difference in the expression of AChR between TEC from MG patients and controls, meaning that the expression of AChR subunits alone is not sufficient to explain the onset of MG.


Subject(s)
Myasthenia Gravis/genetics , Receptors, Cholinergic/genetics , Thymus Gland/metabolism , Adolescent , Adult , Base Sequence , Cells, Cultured , Child , Child, Preschool , DNA Primers/genetics , Epithelial Cells , Epithelium/metabolism , Gene Expression , Humans , In Vitro Techniques , Infant , Middle Aged , Muscles/metabolism , Myasthenia Gravis/metabolism , Polymerase Chain Reaction , RNA, Messenger/genetics , RNA, Messenger/metabolism , Thymus Gland/cytology
SELECTION OF CITATIONS
SEARCH DETAIL
...